Copyright 2014 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
There are numerous differences in cardiovascular disease (CVD) between men and women. Women have a higher prevalence of coronary microvascular dysfunction, heart failure with preserved ejection fraction, Tako-Tsubo syndrome (also known as stress-induced cardiomyopathy), and post–myocardial infarction depression than men. Women also have a greater sensitivity to QT-prolonging medications and higher heart failure mortality with digoxin than men.1,2 A mounting literature further documents important sex differences in pharmacology, including response to β-blockers and angiotensin converting enzyme inhibitors.3
Bairey Merz CN, Regitz-Zagrosek V. The Case for Sex- and Gender-Specific Medicine. JAMA Intern Med. 2014;174(8):1348-1349. doi:10.1001/jamainternmed.2014.320